Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 6,733 All time
- Disclosed funding
- $804.6B 4913 disclosed amounts
- Median round
- $12.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| F Provides AI platform for insurance brokerages to modernize workflows | $25M | Seed+Series AUndisclosed | Fintech | United States | Investors | |
Arctis AICompany profile Arctis AI builds software agents that help construction teams find projects, assess tenders, compare bids and review contracts. Arctis AI builds software agents that help construction teams find projects, assess tenders, compare bids and review contracts. | $1M | Undisclosed | Proptech | Germany | Investors | |
| NA Provides a privacy-first platform for outcome-driven college counseling | $3.2M | Seed | Edtech | United States | Investors | |
| G GridlineCompany profile Provides a turnkey alternatives management platform for private market investing Provides a turnkey alternatives management platform for private market investing | $18.5M | Series A | Fintech | United States | Investors | |
ChamelioCompany profile Chamelio provides AI contract review, negotiation and legal-workflow tools for in-house legal teams. Chamelio provides AI contract review, negotiation and legal-workflow tools for in-house legal teams. | $10M | Seed | Enterprise software | United States | Investors | |
| M Automates SOX testing and internal audit workflows with agentic AI | $4.2M | Seed | AI | United States | Investors | |
| SM Develops real-time microscopy for surgical procedures | €20M | Undisclosed | Healthtech | Belgium | Investors | |
| P Provides agentic AI for accounts receivable automation in B2B finance | $5M | Seed | AI | United Kingdom | Investors | |
AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $24M | Series C second closeSeries C+ | Biotech | United States | Investors | |
| FA Provides AI observability and security platform for enterprises | $30M | Series CSeries C+ | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Unsiloed AI, Model ML, Science Corporation
178rounds5led - 2Andreessen Horowitz (a16z)
Isomorphic Labs, Larridin, Northwood Space
147rounds36led - 3General Catalyst
Rox, Mercor, Clara
142rounds26led - 4NVIDIA
Noeri, Agile Robots, Mercor
103rounds2led - 5Lightspeed
Payhawk, Nominal, Hypersonica
101rounds16led
Latest digests
Archive →Weekly funding picks, November 9–15, 2026
Lucid’s credit commitment, Mercor’s employee tender, factory and clinical robotics, Cocos’s first external capital and Gama’s satellite-power production line.
Browse rounds by topic
Geography
Featured selections
Nahato adds ¥4bn in bank debt for regional and esports expansion
Nahato’s new ¥4bn borrowing brings cumulative financing to ¥10bn. The company plans a Kansai office, recruitment, regional services and gaming expansion.
Read the research →